$XTNT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in XTENT INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in XTENT INC. Get notifications about new insider transactions in XTENT INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.41 | 100 | 141 | 69,800 | 69.9 K to 69.8 K (-0.14 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.40 | 500 | 700 | 69,900 | 70.4 K to 69.9 K (-0.71 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.39 | 300 | 417 | 70,400 | 70.7 K to 70.4 K (-0.42 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.38 | 300 | 414 | 70,700 | 71 K to 70.7 K (-0.42 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.36 | 100 | 136 | 71,000 | 71.1 K to 71 K (-0.14 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.35 | 1,400 | 1,890 | 71,100 | 72.5 K to 71.1 K (-1.93 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.34 | 500 | 670 | 72,500 | 73 K to 72.5 K (-0.68 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.33 | 200 | 266 | 73,000 | 73.2 K to 73 K (-0.27 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.32 | 300 | 396 | 73,200 | 73.5 K to 73.2 K (-0.41 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.31 | 100 | 131 | 73,500 | 73.6 K to 73.5 K (-0.14 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.30 | 800 | 1,040 | 73,600 | 74.4 K to 73.6 K (-1.08 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.25 | 100 | 125 | 74,400 | 74.5 K to 74.4 K (-0.13 %) |
| Oct 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.23 | 300 | 369 | 74,500 | 74.8 K to 74.5 K (-0.40 %) |
| Sep 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.07 | 100 | 207 | 74,800 | 74.9 K to 74.8 K (-0.13 %) |
| Sep 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.05 | 100 | 205 | 74,900 | 75 K to 74.9 K (-0.13 %) |
| Sep 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.01 | 350 | 704 | 75,000 | 75.4 K to 75 K (-0.46 %) |
| Sep 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.00 | 4,400 | 8,800 | 75,350 | 79.8 K to 75.4 K (-5.52 %) |
| Sep 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 1.97 | 50 | 99 | 79,750 | 79.8 K to 79.8 K (-0.06 %) |
| Aug 15 2008 | XTNT | XTENT INC | Andreas Bernard H | VP-Innovation and C ... | Option Exercise | A | 2.10 | 15,000 | 31,500 | 15,000 | |
| Aug 15 2008 | XTNT | XTENT INC | Campbell Randolph E | Chief Technical Off ... | Option Exercise | A | 2.10 | 14,582 | 30,622 | 14,582 | |
| Aug 15 2008 | XTNT | XTENT INC | Campbell Randolph E | Chief Technical Off ... | Option Exercise | A | 2.10 | 10,418 | 21,878 | 10,418 | |
| Aug 15 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Option Exercise | A | 4.50 | 27,050 | 121,725 | 27,050 | |
| Aug 15 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Option Exercise | A | 4.50 | 6,197 | 27,887 | 6,197 | |
| Aug 15 2008 | XTNT | XTENT INC | Hodkinson Anne-Marie | VP Human Resources | Option Exercise | A | 2.10 | 34,995 | 73,490 | 34,995 | |
| Aug 15 2008 | XTNT | XTENT INC | Hodkinson Anne-Marie | VP Human Resources | Option Exercise | A | 2.10 | 7,005 | 14,711 | 7,005 | |
| Aug 15 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | A | 4.50 | 9,427 | 42,422 | 9,427 | |
| Aug 15 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | A | 4.50 | 6,738 | 30,321 | 6,738 | |
| Aug 15 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Option Exercise | A | 2.10 | 14,582 | 30,622 | 14,582 | |
| Aug 15 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Option Exercise | A | 2.10 | 10,418 | 21,878 | 10,418 | |
| Aug 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.60 | 1,000 | 2,600 | 79,800 | 80.8 K to 79.8 K (-1.24 %) |
| Aug 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.57 | 100 | 257 | 80,800 | 80.9 K to 80.8 K (-0.12 %) |
| Aug 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.56 | 100 | 256 | 80,900 | 81 K to 80.9 K (-0.12 %) |
| Aug 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.55 | 2,200 | 5,610 | 81,000 | 83.2 K to 81 K (-2.64 %) |
| Aug 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.53 | 100 | 253 | 83,200 | 83.3 K to 83.2 K (-0.12 %) |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 500 | 200 | 40,000 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 140 | 56 | 40,500 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 500 | 200 | 40,640 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 900 | 360 | 41,140 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 300 | 120 | 42,040 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 5,350 | 2,140 | 42,340 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 1,600 | 640 | 47,690 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 700 | 280 | 49,290 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Option Exercise | M | 0.40 | 10 | 4 | 49,990 | ||
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 500 | 200 | 54,000 | 53.5 K to 54 K (+0.93 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 140 | 56 | 53,500 | 53.4 K to 53.5 K (+0.26 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 500 | 200 | 53,360 | 52.9 K to 53.4 K (+0.95 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 900 | 360 | 52,860 | 52 K to 52.9 K (+1.73 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 300 | 120 | 51,960 | 51.7 K to 52 K (+0.58 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 5,350 | 2,140 | 51,660 | 46.3 K to 51.7 K (+11.55 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 1,600 | 640 | 46,310 | 44.7 K to 46.3 K (+3.58 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 700 | 280 | 44,710 | 44 K to 44.7 K (+1.59 %) | |
| Jul 22 2008 | XTNT | XTENT INC | Walsh Brian J | Buy | M | 0.40 | 10 | 4 | 44,010 | 44 K to 44 K (+0.02 %) | |
| Jul 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 2.43 | 3,500 | 8,505 | 83,300 | 86.8 K to 83.3 K (-4.03 %) |
| Jun 20 2008 | XTNT | XTENT INC | Split Rock Partners LLC | 10% Owner | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 20 2008 | XTNT | XTENT INC | Will Allan R | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 20 2008 | XTNT | XTENT INC | Carusi Michael A | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 19 2008 | XTNT | XTENT INC | FLAHERTY ROBERT E | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 19 2008 | XTNT | XTENT INC | Unkart Edward W | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 19 2008 | XTNT | XTENT INC | EAGLE MICHAEL L | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Option Exercise | A | 2.88 | 10,000 | 28,800 | 10,000 | |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 459,656 | 461.7 K to 459.7 K (-0.43 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 461,656 | 463.7 K to 461.7 K (-0.43 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 463,656 | 465.7 K to 463.7 K (-0.43 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 465,656 | 467.7 K to 465.7 K (-0.43 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 467,656 | 469.7 K to 467.7 K (-0.43 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 2,000 | 0 | 469,656 | 471.7 K to 469.7 K (-0.42 %) |
| Jun 19 2008 | XTNT | XTENT INC | Plain Henry A JR | Director | Gift | G | 0.00 | 10,000 | 0 | 471,656 | 481.7 K to 471.7 K (-2.08 %) |
| Jun 19 2008 | XTNT | XTENT INC | TAYLOR ARTHUR T | Director | Option Exercise | A | 2.88 | 30,000 | 86,400 | 30,000 | |
| Jun 19 2008 | XTNT | XTENT INC | Smith Christopher M | Director | Option Exercise | A | 2.88 | 30,000 | 86,400 | 30,000 | |
| Apr 24 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Sell | S | 4.00 | 2,000 | 8,000 | 44,000 | 46 K to 44 K (-4.35 %) |
| Apr 24 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Sell | S | 4.25 | 1,000 | 4,250 | 46,000 | 47 K to 46 K (-2.13 %) |
| Apr 24 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Sell | S | 4.48 | 2,000 | 8,960 | 47,000 | 49 K to 47 K (-4.08 %) |
| Apr 24 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Sell | S | 4.63 | 1,000 | 4,625 | 49,000 | 50 K to 49 K (-2.00 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.56 | 500 | 1,780 | 86,800 | 87.3 K to 86.8 K (-0.57 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.52 | 200 | 704 | 87,300 | 87.5 K to 87.3 K (-0.23 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.50 | 200 | 700 | 87,500 | 87.7 K to 87.5 K (-0.23 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.45 | 200 | 690 | 87,700 | 87.9 K to 87.7 K (-0.23 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.44 | 100 | 344 | 87,900 | 88 K to 87.9 K (-0.11 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.43 | 1,700 | 5,831 | 88,000 | 89.7 K to 88 K (-1.90 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.42 | 200 | 684 | 89,700 | 89.9 K to 89.7 K (-0.22 %) |
| Jun 03 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.40 | 400 | 1,360 | 89,900 | 90.3 K to 89.9 K (-0.44 %) |
| May 01 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 3.50 | 3,500 | 12,250 | 89,050 | 92.6 K to 89.1 K (-3.78 %) |
| Apr 03 2008 | XTNT | XTENT INC | Grainger Jeffry J | VP-Corp Affairs & G ... | Sell | S | 4.94 | 3,000 | 14,820 | 109,500 | 112.5 K to 109.5 K (-2.67 %) |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | A | 5.00 | 16,662 | 83,310 | 16,662 | |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | M | 3.50 | 798 | 2,793 | 140,340 | |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | M | 3.50 | 202 | 707 | 141,138 | |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | A | 5.00 | 8,331 | 41,655 | 8,331 | |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 5.05 | 798 | 4,030 | 0 | 798 to 0 (-100.00 %) |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Buy | M | 3.50 | 798 | 2,793 | 798 | 0 to 798 |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 5.00 | 202 | 1,010 | 0 | 202 to 0 (-100.00 %) |
| Apr 02 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Buy | M | 3.50 | 202 | 707 | 202 | 0 to 202 |
| Apr 02 2008 | XTNT | XTENT INC | Grainger Jeffry J | VP-Corp Affairs & G ... | Option Exercise | A | 5.00 | 13,536 | 67,680 | 13,536 | |
| Apr 02 2008 | XTNT | XTENT INC | Grainger Jeffry J | VP-Corp Affairs & G ... | Option Exercise | A | 5.00 | 6,770 | 33,850 | 6,770 | |
| Apr 02 2008 | XTNT | XTENT INC | Grainger Jeffry J | VP-Corp Affairs & G ... | Sell | S | 5.00 | 1,200 | 6,000 | 112,500 | 113.7 K to 112.5 K (-1.06 %) |
| Apr 02 2008 | XTNT | XTENT INC | Grainger Jeffry J | VP-Corp Affairs & G ... | Sell | S | 5.05 | 800 | 4,040 | 113,700 | 114.5 K to 113.7 K (-0.70 %) |
| Apr 02 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Option Exercise | A | 5.00 | 13,535 | 67,675 | 13,535 | |
| Apr 02 2008 | XTNT | XTENT INC | Walsh Brian J | VP-Sales & Marketin ... | Option Exercise | A | 5.00 | 6,771 | 33,855 | 6,771 | |
| Apr 02 2008 | XTNT | XTENT INC | Hodkinson Anne-Marie | VP Human Resources | Option Exercise | A | 5.00 | 869 | 4,345 | 869 | |
| Apr 02 2008 | XTNT | XTENT INC | Hodkinson Anne-Marie | VP Human Resources | Option Exercise | A | 5.00 | 82 | 410 | 82 | |
| Apr 02 2008 | XTNT | XTENT INC | Campbell Randolph E | Chief Technical Off ... | Option Exercise | A | 5.00 | 13,536 | 67,680 | 13,536 | |
| Apr 02 2008 | XTNT | XTENT INC | Campbell Randolph E | Chief Technical Off ... | Option Exercise | A | 5.00 | 6,770 | 33,850 | 6,770 | |
| Apr 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Option Exercise | A | 5.00 | 13,537 | 67,685 | 13,537 | |
| Apr 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Option Exercise | A | 5.00 | 6,769 | 33,845 | 6,769 | |
| Apr 02 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 5.00 | 3,500 | 17,500 | 92,550 | 96.1 K to 92.6 K (-3.64 %) |
| Apr 02 2008 | XTNT | XTENT INC | Andreas Bernard H | VP-Research & Devel ... | Option Exercise | A | 5.00 | 10,931 | 54,655 | 10,931 | |
| Apr 02 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Option Exercise | A | 5.00 | 40,610 | 203,050 | 40,610 | |
| Apr 02 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Option Exercise | A | 5.00 | 20,308 | 101,540 | 20,308 | |
| Apr 02 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 5.00 | 1,198 | 5,990 | 628,700 | 629.9 K to 628.7 K (-0.19 %) |
| Apr 02 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 5.05 | 802 | 4,050 | 629,898 | 630.7 K to 629.9 K (-0.13 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.85 | 300 | 2,055 | 630,700 | 631 K to 630.7 K (-0.05 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.86 | 566 | 3,883 | 631,000 | 631.6 K to 631 K (-0.09 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.87 | 201 | 1,381 | 631,566 | 631.8 K to 631.6 K (-0.03 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.90 | 199 | 1,373 | 631,767 | 632 K to 631.8 K (-0.03 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.91 | 33 | 228 | 631,966 | 632 K to 632 K (-0.01 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.94 | 33 | 229 | 631,999 | 632 K to 632 K (-0.01 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.95 | 66 | 459 | 632,032 | 632.1 K to 632 K (-0.01 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 6.98 | 201 | 1,403 | 632,098 | 632.3 K to 632.1 K (-0.03 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 7.46 | 201 | 1,499 | 632,299 | 632.5 K to 632.3 K (-0.03 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 7.50 | 67 | 503 | 632,500 | 632.6 K to 632.5 K (-0.01 %) |
| Mar 05 2008 | XTNT | XTENT INC | Casciaro Gregory D | President and CEO | Sell | S | 7.52 | 133 | 1,000 | 632,567 | 632.7 K to 632.6 K (-0.02 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Option Exercise | M | 3.50 | 1,000 | 3,500 | 141,340 | |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.86 | 68 | 466 | 0 | 68 to 0 (-100.00 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.90 | 201 | 1,387 | 68 | 269 to 68 (-74.72 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.91 | 33 | 228 | 269 | 302 to 269 (-10.93 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.94 | 33 | 229 | 302 | 335 to 302 (-9.85 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.95 | 67 | 466 | 335 | 402 to 335 (-16.67 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 6.98 | 199 | 1,389 | 402 | 601 to 402 (-33.11 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 7.46 | 199 | 1,485 | 601 | 800 to 601 (-24.87 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 7.50 | 66 | 495 | 800 | 866 to 800 (-7.62 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Sell | S | 7.52 | 134 | 1,008 | 866 | 1,000 to 866 (-13.40 %) |
| Mar 04 2008 | XTNT | XTENT INC | Kahlenberg Timothy D | Chief Financial Off ... | Buy | M | 3.50 | 1,000 | 3,500 | 1,000 | 0 to 1,000 |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.49 | 100 | 749 | 96,050 | 96.2 K to 96.1 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.30 | 100 | 730 | 96,150 | 96.3 K to 96.2 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.18 | 100 | 718 | 96,250 | 96.4 K to 96.3 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.16 | 300 | 2,148 | 96,350 | 96.7 K to 96.4 K (-0.31 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.15 | 200 | 1,430 | 96,650 | 96.9 K to 96.7 K (-0.21 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.14 | 200 | 1,428 | 96,850 | 97.1 K to 96.9 K (-0.21 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.12 | 200 | 1,424 | 97,050 | 97.3 K to 97.1 K (-0.21 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.11 | 400 | 2,844 | 97,250 | 97.7 K to 97.3 K (-0.41 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.10 | 100 | 710 | 97,650 | 97.8 K to 97.7 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.07 | 100 | 707 | 97,750 | 97.9 K to 97.8 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.06 | 100 | 706 | 97,850 | 98 K to 97.9 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.01 | 200 | 1,402 | 97,950 | 98.2 K to 98 K (-0.20 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 7.00 | 300 | 2,100 | 98,150 | 98.5 K to 98.2 K (-0.30 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.95 | 200 | 1,390 | 98,450 | 98.7 K to 98.5 K (-0.20 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.93 | 100 | 693 | 98,650 | 98.8 K to 98.7 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.89 | 100 | 689 | 98,750 | 98.9 K to 98.8 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.87 | 100 | 687 | 98,850 | 99 K to 98.9 K (-0.10 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.86 | 400 | 2,744 | 98,950 | 99.4 K to 99 K (-0.40 %) |
| Mar 04 2008 | XTNT | XTENT INC | Marco Philippe H | VP-QA, Clinical & R ... | Sell | S | 6.85 | 100 | 685 | 99,350 | 99.5 K to 99.4 K (-0.10 %) |